Ringer lactate

ApprovedSmall molecule

YYuria-Pharm

Ringer lactate is one of 247 small molecule programs targeting Acute Pancreatitis. It is currently in Approved.

Indications

Total Trials

Active Trials

246

Competitors

Pipeline

Status by Indication[3][1]

Indication

Acute PancreatitisActive, not recruiting

Diabetic KetoacidosisActive, not recruiting

Post Operative Nausea and VomitingActive, not recruiting

PneumoniaActive, not recruiting

PeritonitisActive, not recruiting

SepsisActive, not recruiting

PancreatitisActive, not recruiting

Systemic SclerosisActive, not recruiting

SclerodermaActive, not recruiting

Acute PancreatitisPhase 2/Phase 3

Active, not recruiting

Diabetic KetoacidosisApproved

Active, not recruiting

Post Operative Nausea and VomitingPhase 3

Active, not recruiting

PneumoniaApproved

Active, not recruiting

PeritonitisApproved

Active, not recruiting

SepsisApproved

Active, not recruiting

PancreatitisPreclinical

Active, not recruiting

Systemic SclerosisPhase 2

Active, not recruiting

SclerodermaPhase 2

Active, not recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

Ringer lactate

YYuria-Pharm

Approved

1 2

Innohep

Alnylam Pharmaceuticals

Preclinical

1 3

Neutrexin

WWest Japan Thoracic Oncology Group

Preclinical

12 4

Retrovir

BBp Consulting, Inc

Preclinical

2 5

Tagamet

DDT MedTech, LLC

Preclinical

1 6

Pepcid

KKenvue Brands

Preclinical

1 7

Aciphex

Akero Therapeutics

Preclinical

1 8

Protonix

WWyeth-Lederle Vaccines

Preclinical

1 9

Alka-Seltzer

AAbbott

Preclinical

1 10

Tylenol

KKenvue Brands

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Post-ApprovalNot yet recruiting

Sepsis

NCT07035509

Clinical

Trials by Indication[1]

Sepsis2 trials

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.

Completed·YYuria-Pharm·Phase 4·NCT03764085·180 enrolled

Randomized Control Study in REsuscitation of SEpsis Trial

Not yet recruiting·FFundación Cardioinfantil Instituto de Cardiología·Phase 4·NCT07035509·150 enrolled

Acute Pancreatitis2 trials

Dextran 40 Plus Ringer's Lactate Vs. Ringer's Lactate Alone for Fluid Resuscitation in Acute Pancreatitis

Recruiting·SSatu Mare County Emergency Hospital·N/A·NCT06835023·100 enrolled

Fluid Resuscitation in Acute Pancreatitis

Unknown status·UUniversity Hospital Rijeka·Phase 2/3·NCT02709044·903 enrolled

Cardiopulmonary Bypass2 trials

Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery

Completed·RRajaie Cardiovascular Medical and Research Center·Phase 3·NCT05223361·120 enrolled

Comparative Analysis Between Ringer's Lactate vs Plasma Lyte-A as Cardiopulmonary Bypass Prime

Unknown status·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 3·NCT03043131·60 enrolled

Efficacy and Safety1 trial

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns

Completed·YYuria-Pharm·Phase 4·NCT04152096·118 enrolled

Children1 trial

Comparison of Ringer Lactate and Isotonic Acetate Solution as Perioperative Maintenance Fluid for Children

Unknown status·PPost Graduate Institute of Medical Education and Research, Chandigarh·N/A·NCT02936167·50 enrolled

14 more indications

Open Heart Surgery1 trial

Effect of Prime Solution on Fluid Balance After Open Heart Surgery

Completed·UUniversity of Helsinki·Phase 4·NCT00797589·35 enrolled

Conditioning1 trial

Clearance Rate of Peritoneal Fluid After Full Conditioning Pneumoperitoneum

Completed·UUniversity Hospital, Gasthuisberg·N/A·NCT01344499·20 enrolled

Intraocular Pressure1 trial

Influence of Perioperative Fluid Management on Intraocular Pressure During Hynecologic Laparoscopic Pelvic Surgery

Unknown status·ZZiv Hospital·N/A·NCT01676064·50 enrolled

Diabetic Ketoacidosis1 trial

0.9% Saline Versus Balanced Solutions in Severe Diabetic Ketoacidosis

Completed·TTunis University·Phase 4·NCT05808972·92 enrolled

Post Operative Nausea and Vomiting1 trial

An Evaluation the Effect of Superhydration Versus Dextrose 10% for Prevention of Post Operative Nausea and Vomiting After Laparoscopic Cholecystectomy (prospective Randomised Controlled Study)

Completed·—·Phase 3·NCT06847594·204 enrolled

Cesarean Delivery1 trial

Transthoracic Echocardiographic Monitoring of Cardiac Output Effects of Colloid Preload and Crystalloid Coload During Cesarean Delivery Under Spinal Anesthesia

Completed·SSameh Fathy·N/A·NCT06654687·162 enrolled

Pneumonia1 trial

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia

Completed·YYuria-Pharm·Phase 4·NCT03824457·150 enrolled

Pancreatitis1 trial

Evidence Based Management of Acute Biliary Pancreatitis

Completed·ZZagazig University··NCT04615702·30 enrolled

Peritonitis1 trial

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Peritonitis

Completed·YYuria-Pharm·Phase 4·NCT03771170·180 enrolled

Adult1 trial

Liberal Versus Restrictive Fluid Protocols in Adults

Completed·—·Phase 2·NCT03697330·80 enrolled

Fluid Resuscitation1 trial

Fluid Resuscitation in Burn Patients

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT03118362·28 enrolled

Anesthesia1 trial

Fluid Management in the Post Anesthesia Care Unit

Unknown status·RRabin Medical Center·Phase 4·NCT03799250·200 enrolled

Systemic Sclerosis1 trial

Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis

Terminated·AAssistance Publique Hopitaux De Marseille·Phase 2·NCT02558543·40 enrolled

Scleroderma1 trial

SCLERoderma et Adipose-DErived Stroma Cells

Unknown status·AAssistance Publique Hopitaux De Marseille·Phase 2·NCT02866552·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 22 trial records for Ringer lactate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ringer lactate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ringer lactate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Yuria-Pharm company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: YYuria-Pharm

Ringer lactate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Trials by Indication[1]

Sepsis2 trials

Acute Pancreatitis2 trials

Cardiopulmonary Bypass2 trials

Efficacy and Safety1 trial

Children1 trial

Open Heart Surgery1 trial

Conditioning1 trial

Intraocular Pressure1 trial

Diabetic Ketoacidosis1 trial

Post Operative Nausea and Vomiting1 trial

Cesarean Delivery1 trial

Pneumonia1 trial

Pancreatitis1 trial

Peritonitis1 trial

Adult1 trial

Fluid Resuscitation1 trial

Anesthesia1 trial

Systemic Sclerosis1 trial

Scleroderma1 trial

References

Drug Info

Quick Facts

Related News